Evaluating the influence of vaccine archetypes and epidemiological conditions on clinical trial metrics for tuberculosis vaccine candidates.

Andrews JR, Hermans S, White RG, García-Basteiro AL, Croda J, Cobelens F

Open source

DOI
10.1016/j.vaccine.2026.129097
Published
2026 Oct 3
Container
Vaccine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2026.129097,
  title = {Evaluating the influence of vaccine archetypes and epidemiological conditions on clinical trial metrics for tuberculosis vaccine candidates.},
  author = {Andrews JR and Hermans S and White RG and García-Basteiro AL and Croda J and Cobelens F},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2026.129097},
  url = {https://doi.org/10.1016/j.vaccine.2026.129097}
}

RIS

TY  - JOUR
TI  - Evaluating the influence of vaccine archetypes and epidemiological conditions on clinical trial metrics for tuberculosis vaccine candidates.
AU  - Andrews JR
AU  - Hermans S
AU  - White RG
AU  - García-Basteiro AL
AU  - Croda J
AU  - Cobelens F
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2026.129097
UR  - https://doi.org/10.1016/j.vaccine.2026.129097
ER  - 

APA

JR, A., S, H., RG, W., AL, G., J, C., & F, C. (2026). Evaluating the influence of vaccine archetypes and epidemiological conditions on clinical trial metrics for tuberculosis vaccine candidates.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.129097

Source records